Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trial

References

• Dubinsky RM, Kabbani H, El-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959–65
   Google Scholar
• Engberg IB, Gröndahl GB, Thibom K. Patients’ experience of herpes zoster and postherpetic neuralgia. J Advanced Nursing 1995;21:427–33
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996;67:241–51
   PubMed Web of Science ®Google Scholar
• Watson CP, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1988;51:1166–71
   Google Scholar
• Kinshore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves post-herpetic neuralgia. Clin Pharmacol Ther 1990;47:305–12
   PubMed Web of Science ®Google Scholar
• Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427–32
   PubMed Web of Science ®Google Scholar
• Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671–3
   PubMed Web of Science ®Google Scholar
• Watson CPN. The treatment of neuropathic pain: anti- depressants and opioids. Clin J Pain 2000;16(Suppl):S49–S55
   Google Scholar
• AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatrics Assoc 2002;50(Suppl):S205–S224
   Google Scholar
• Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Ann Neurol 1994;35:S54–S56
   PubMed Web of Science ®Google Scholar
• Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533–8
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized, controlled trial. J Am Med Assoc 1998;280:1837–42
   PubMed Web of Science ®Google Scholar
• Gee NS, Brown JP, Dissanayake VU, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the α2-δ subunit of a calcium channel. J Biol Chem 1996;271:5768–76
   PubMed Web of Science ®Google Scholar
• Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002;42:229–36
   PubMed Web of Science ®Google Scholar
• Dooley DJ, Mieske CA, Borosky SA. Inhibition of K⁺–evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 2000:280:107–10
   Google Scholar
• Dooley DJ, Donovan CM, Pugsley TA. Stimulus-dependent nodulation of [3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000;295: 1086–93
   Google Scholar
• Maneuf YP, Hughes J, McKnight AT. Gabapentin inhibits the substance P–facilitated K+–evoked release of [3H]glutamate from rat caudal trigeminal nucleus slices. Pain 2001;93: 191–6
   Google Scholar
• Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV). Epilepsy Res 1999;34:1–41
   PubMed Web of Science ®Google Scholar
• Welty D, Wang Y, Busch JA, et al. Pharmacokinetics (PK) and pharmacodynamics (PD) of CI-1008 (pregabalin) and gaba- pentin in rats with maximal electroshock [abstract]. Epilepsia 1997;38\(Suppl 8):35 [abstract 1.110]
   Google Scholar
• Rosenstock J, Tuchman M, Sharma U, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double- blind, placebo-controlled trial. Pain 2004;110:628–38
   PubMed Web of Science ®Google Scholar
• Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004:63:2104–10
   PubMed Web of Science ®Google Scholar
• Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253–60
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Corbin AE, Young Jr JP, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo- controlled trial. Neurology 2003;60:1274–83
   PubMed Web of Science ®Google Scholar
• Sabatowski R, Gálvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with postherpetic neuralgia: results of a randomised, placebo- controlled clinical trial. Pain 2004;109:26–35
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005;115:254–63
   PubMed Web of Science ®Google Scholar
• Randinitis EJ, Posvar EL, Alvey CW, et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 2003;43:277–83
   PubMed Web of Science ®Google Scholar
• Bockbrader HN, Burger P, Corrigan BW. Population pharmaco- kinetics of pregabalin in healthy volunteers, renally impaired patients, and patients with chronic pain. Presented at the annual meeting of the American Pain Society; March 14–17, 2002; Baltimore, MD
   Google Scholar
• Farrar JT, Young Jr JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical rating scale. Pain 2001;94:149–58
   PubMed Web of Science ®Google Scholar
• Rice ASC, Maton S, Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001;94:215–24
   Google Scholar